An observational study in Heart Failure, Ventricular Dysfunction and Sudden Death, sponsored by Medical University of Graz. Status unknown at 1 site in Austria. Per ClinicalTrials.gov, last updated 2021-09-14.
Sponsored by Medical University of Graz · Observational
Background: The wearable cardioverter defibrillator (WCD) is an established treatment option for patients at high risk for ventricular tachycardia / ventricular fibrillation (VT/VF), either in whom this risk may only be temporarily present, or in patients at high risk for sudden cardiac death (SCD) or after VT/VF in whom an implantable cardioverter defibrillator (ICD is currently not possible for other reasons (infection, recent MI \<40days, recent PCI/CABG \< 3months etc.).
Methods: Comprehensive registry including all patients in Austria who received a WCD in 2010-2016.
Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients
6,331 studies on the registry are indexed under Heart Failure; 1,396 are open to participants now.
This study's planned enrollment of 450 is above the median of 200 across 1,983 observational studies indexed under Heart Failure.
Browse Heart Failure studies →Medical University of Graz is the lead sponsor of 471 studies on the registry; 98 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Comprehensive registry including all patients in all Austrian centers who received a WCD in 2010-2016.
Inclusion Criteria:
Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients
Number of participants treated with WCD-treated ventricular arrhythmias
Number of participants treated with WCD-treated ventricular arrhythmias
Time frame: during WCD wearing period; average of 1 year
Plan to share: Undecided — possible
No publications or documents are linked to this record.
The record gives a start of Nov 2014, a primary completion of Dec 2021 and a completion of Mar 2022. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.